Results 51 to 60 of about 170,023 (183)

Test system for the detection of binding antibodies to interferon beta-1a for clinical use

Биопрепараты: Профилактика, диагностика, лечение, 2018
Test system for determining the presence of binding antibodies to interferon beta-1a (BAB to IFN beta-1a) in serum using ELISA has been developed.
E. A. Kuzminova, T. Yu. Ostroukhova, A. V. Grachev, E. L. Morozova   +3 more
doaj  

Rickettsia rickettsii virulence determinants RARP2 and RapL mitigate IFN-β signaling in primary human dermal microvascular endothelial cells

mBio
We compared the growth characteristics of a virulent Rickettsia rickettsii strain (Sheila Smith) to an attenuated R. rickettsii stain (Iowa) and a non-pathogenic species (R.
Liam Fitzsimmons, DeAnna Bublitz, Tina Clark, Ted Hackstadt   +3 more
doaj   +1 more source

Multiple Sclerosis-Associated Uveitis Therapy: Is Modern Better than Old Reliable?

Journal of Clinical & Translational Ophthalmology
Background: Uveitis, although a rare complication of multiple sclerosis (MS), poses a significant challenge in clinical management. Traditional treatments like corticosteroids, immunosuppressants, and surgical interventions often provide limited efficacy.
Wesley Burrow, Armand Ceniza, Brian Kan, Skyler Colwell, Jorge Cervantes   +4 more
doaj   +1 more source

Characterization of regulatory (interferon-alpha/beta) and accessory (LAF/IL 1) monokine activities from liver granuloma macrophages of Schistosoma mansoni-infected mice. [PDF]

, 1987
David E. Elliott, V F Righthand, Dov L. Boros   +2 more
openalex   +1 more source

285. Construction and Testing of a Versatile One-Plasmid Regulated Expression System in Mice Using the Interferon beta Gene [PDF]

, 2007

openalex   +1 more source

The emergence of Eszett (ß)-interferon: A PubMed-based assessment

Medical Research Journal
Interferon beta (IFN-β), specifically IFN-β1a (or IFN-β1alpha), is used to treat multiple sclerosis. A linguistic error in which the Greek letter beta (β) has been replaced by the German letter Eszett (ß) has resulted in the emergence of a “new” and non ...
Jaime A. Teixeira da Silva
doaj   +1 more source

Using Discrete Choice Experiment to Determine Willingness to Pay for Medicine Interferon-Beta by Multiple Sclerosis Patients [PDF]

, 2018
Farimah Rahimi, Hamidreza Rasekh, Farzad Peiravian, Ezatollah Abbasian   +3 more
openalex   +1 more source

Efficacy and safety of the new drug against multiple sclerosis «PEGylated Interferon beta-1a Human» in monkeys compared with unmodified interferon beta-1a

Биопрепараты: Профилактика, диагностика, лечение, 2018
The article presents the results of studies on the safety and efficacy of long-acting drug for the treatment of multiple sclerosis on the basis of recombinant human interferon beta-1a «PEGylated interferon beta-1a Human» (PEG IFN beta-1a) in monkeys ...
N. A. Spirina, Ja. Ju. Ustjugov, A. A. Aleksandrov, M. V. Artjuhova, A. B. Dzhelija   +4 more
doaj  

Development of ADA Against Recombinant Human Interferon Beta in Immune Tolerant Mice Requires Rapid Recruitment of CD4+ T Cells, Induces Formation of Germinal Centers but Lacks Susceptibility for (Most) Adjuvants [PDF]

, 2014
Grzegorz Kijanka, Melody Sauerborn, Louis Boon, Huub Schellekens, Vera Brinks   +4 more
openalex   +1 more source

C5aR2 Regulates STING-Mediated Interferon Beta Production in Human Macrophages. [PDF]

Cells, 2023
Wright O, Harris A, Nguyen VD, Zhou Y, Durand M, Jayyaratnam A, Gormley D, O'Neill LAJ, Triantafilou K, Nichols EM, Booty LM.   +10 more
europepmc   +1 more source